Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study-Reference-Cited by-同舟云学术

Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study

Published:2018-02 Issue: Volume:52 Page:41-47
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Lyngbakken Magnus Nakrem,Pervez Mohammad Osman,Brynildsen Jon,Pedersen Marit Holmefjord,Sølvernes Janne,Christensen Geir,Høiseth Arne Didrik,Omland Torbjørn,Røsjø Helge

Funder

Norwegian Research Council

Akershus University Hospital

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference34 articles.

1. American Thoracic Society Committee on Dyspnea, An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea;Parshall;Am. J. Respir. Crit. Care Med.,2012

2. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study;He;Arch. Intern. Med.,2001

3. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study;Januzzi;Eur. Heart J.,2006

4. Biomarkers and diagnostics in heart failure;Gaggin;Biochim. Biophys. Acta,2013

5. Phosphate and FGF-23;Juppner;Kidney Int.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating MicroRNA-210 Concentrations in Patients with Acute Heart Failure: Data from the Akershus Cardiac Examination 2 Study;Clinical Chemistry;2021-03-30

2. Fibroblast growth factor 23 and the quest for the Holy Grail in heart failure: will the Crusaders be forced to surrender?;European Journal of Heart Failure;2020-03-04

3. FGF23: Clinical usefulness and analytical evolution;Clinical Biochemistry;2019-04

4. Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients;Clinical Biochemistry;2018-11